Article info

Download PDFPDF
The legacy effect: 4.5 years of a chlorthalidone-based antihypertensive regimen reduces cardiovascular mortality and prolongs cardiovascular disease-free survival at 22 years for older patients with isolated systolic hypertension

Authors

  • Gerald William Smetana Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  1. Correspondence to: Gerald W Smetana
    Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center and Harvard Medical School, Shapiro 621D, 330 Brookline Ave., Boston, MA 02215, USA; gsmetana{at}bidmc.harvard.edu
View Full Text

Citation

Smetana GW
The legacy effect: 4.5 years of a chlorthalidone-based antihypertensive regimen reduces cardiovascular mortality and prolongs cardiovascular disease-free survival at 22 years for older patients with isolated systolic hypertension

Publication history

  • First published April 17, 2012.
Online issue publication 
November 28, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.